A phase I study of a novel IAP inhibitor APG-1387 as a monotherapy or in combination with pembrolizumab in treatments of patients with advanced solid tumors.

被引：6
|
作者：
Rasco, Drew W.
Li, Yufeng
Tang, Yuefen
Men, Lichuang
Wang, Hengbang
Ji, Jiao
Liang, Zhiyan
Sun, Joan
Amaya, Alex
Huang, Yingjie
Yang, Dajun
Zhai, Yifan
机构：
[1] START, San Antonio, TX USA
[2] Ascentage Pharma Grp Inc, Rockville, MD USA
[3] Ascentage Pharma Suzhou Co Ltd, Suzhou, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.3125
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3125
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors.
    Cescon, David W.
    Hansen, Aaron Richard
    Razak, Albiruni Ryan Abdul
    Stayner, Lee-Anne
    Hilton, John Frederick
    Renouf, Daniel John
    Denny, Trisha
    Fletcher, Graham
    Mak, Tak W.
    Bray, Mark R.
    Bedard, Philippe L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] A phase I study of IPI-926, a novel hedgehog pathway inhibitor, in patients (pts) with advanced or metastatic solid tumors.
    Rudin, C. M.
    Jimeno, A.
    Miller, W. H.
    Eigl, B. J.
    Gettinger, S. N.
    Chang, A. L. S.
    Faia, K.
    Sweeney, J.
    Loewen, G.
    Ross, R. W.
    Weiss, G. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] Final results of a phase I study of the combination of a novel cell cycle inhibitor ON 01910.Na with gemcitabine in patients with advanced pancreatic and other solid tumors.
    Ma, W. W.
    Messersmith, W. A.
    Dy, G. K.
    Freas, E.
    Whitworth, A.
    Wilhelm, F.
    Eckhardt, S. G.
    Adjei, A. A.
    Jimeno, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] Phase I study of MEDI0639 in patients with advanced solid tumors.
    Falchook, Gerald Steven
    Dowlati, Afshin
    Naing, Aung
    Gribbin, Matthew Joseph
    Jenkins, David William
    Chang, Linda L.
    Lai, Dominic W.
    Smith, David C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] A phase I study of lenalidomide and weekly docetaxel in patients with advanced solid tumors.
    Papadopoulos, K
    Mendelson, D
    Preston, GG
    Lopez, AM
    Ricart, AD
    Schwartz, G
    Needle, MN
    Gordon, MS
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9116S - 9116S
  • [36] Phase I study of sequential sapacitabine and seliciclib in patients with advanced solid tumors.
    Shapiro, Geoffrey
    Kwak, Eunice Lee
    Cleary, James M.
    Tolaney, Sara
    Gandhi, Leena
    Clark, Jeffrey W.
    Wolanski, Andrew
    Frame, Sheelagh
    Rodig, Scott J.
    Chiao, Judy H.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Phase I and pharimacokinetic trial of a novel inhibitor of NAD biosynthesis in patients with solid tumors.
    Holen, KD
    Bolling, C
    Saltz, LB
    Graefe, T
    Ty, V
    Sogo, N
    Starkmann, H
    Burk, KH
    Hollywood, E
    Hanauske, AR
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6158S - 6158S
  • [38] Phase 1 dose escalation study of FGFR4 inhibitor in combination with pembrolizumab in advanced solid tumors patients
    Xu, Jianming
    Cui, Jiuwei
    Jiang, Haiping
    Zeng, Yan
    Cong, Xiuyu
    CANCER MEDICINE, 2023, 12 (07): : 7762 - 7771
  • [39] Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma
    Fujiwara, Yutaka
    Takahashi, Yasuo
    Okada, Morihito
    Kishimoto, Takumi
    Kondo, Shunsuke
    Fujikawa, Koshi
    Hayama, Manabu
    Sugeno, Masatoshi
    Ueda, Shinya
    Komuro, Keiko
    Lanasa, Mark
    Nakano, Takashi
    ONCOLOGIST, 2022, 27 (09): : E703 - E722
  • [40] An open label phase I/Ila study to evaluate the safety and efficacy of CCS1477 as monotherapy and in combination in patients with advanced solid/metastatic tumors.
    De Bono, Johann S.
    Cojocaru, Elena
    Plummer, Elizabeth Ruth
    Knurowski, Tomasz
    Clegg, Karen
    Ashby, Fay
    Pegg, Neil
    West, William
    Brooks, Anthony Nigel
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345